Arteris Announces New Employment Inducement Grants

Rhea-AI Summary

Arteris (Nasdaq:AIP) announced that its compensation committee granted an aggregate of 477,208 restricted stock units (RSUs) as inducement awards to 25 newly hired employees under the company’s 2022 Employee Inducement Incentive Plan. The grants were made in accordance with Nasdaq Listing Rule 5635(c)(4), approved by the board of directors, with an effective RSU grant date of January 15, 2026. The awards are intended as employment inducements for recent hires.

News Market Reaction – AIP

-4.72%

-4.72% Session close to close

In the Jan 20 session, AIP declined 4.72%, reflecting a moderate negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

Market Context

This announcement details routine employment inducement grants totaling 477,208 RSUs to 25 new hires...

Analysis

This announcement details routine employment inducement grants totaling 477,208 RSUs to 25 new hires under Arteris’ 2022 plan, made in line with Nasdaq Listing Rule 5635(c)(4). In context, the company recently reported Q3 2025 revenue of $17.4M with strong ACV, royalties, and RPO growth, and maintains an S-3 shelf for up to $200,000,000 in securities, including a $75,000,000 ATM. Investors may watch future equity issuance and ongoing execution on acquisitions and customer wins.

Key Figures

RSU inducement grants: 477,208 RSUs Employees granted: 25 employees Shelf registration capacity: $200,000,000 +5 more

8 metrics

RSU inducement grants 477,208 RSUs Aggregate awards to 25 new employees under 2022 Inducement Plan

Employees granted 25 employees Recipients of inducement RSU awards effective Jan 15, 2026

Shelf registration capacity $200,000,000 Total potential offerings under S-3 shelf registration

ATM program size $75,000,000 Common stock that may be sold via at-the-market program

Sales agent fee 3.0% Jefferies’ commission on gross proceeds from ATM sales

Q3 2025 revenue $17.4M Q3 2025 results, +18% year-over-year

Q3 2025 ACV+royalties $74.9M Q3 2025, +24% year-over-year

Q3 2025 RPO $104.7M Q3 2025, +34% year-over-year and first time above $100M

Historical Context

5 past events · Latest: Jan 14 (Positive)

Pattern 5 events

Date	Event	Sentiment	24h Move	Catalyst
Jan 14	Acquisition close	Positive	-2.1%	Closed Cycuity acquisition, adding semiconductor cybersecurity assurance technology.
Dec 11	Acquisition announcement	Positive	+0.3%	Definitive agreement to acquire Cycuity and expand security-focused portfolio.
Dec 02	Customer win	Positive	+2.5%	Black Sesame licensed Ncore 3 and FlexNoC 5 for next-gen automotive SoCs.
Nov 11	AI partnership	Positive	+3.8%	Blaize adopted FlexNoC 5 IP to enhance scalable edge AI platform.
Nov 04	Earnings and guidance	Positive	-5.9%	Q3 2025 growth metrics and updated Q4/full-year 2025 guidance.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Pattern Detected

Recent product and AI partnership announcements tended to see positive price alignment, while acquisitions and earnings updates more often showed negative or muted reactions.

Recent Company History

Over the last few months, Arteris reported multiple growth-oriented milestones. On Nov 4, 2025, Q3 2025 results showed revenue of $17.4M with strong ACV, royalties, and RPO growth, though shares fell 5.88%. Subsequent AI and customer wins on Nov 11 and Dec 2, 2025 saw gains of 3.82% and 2.5%. The Cycuity acquisition announcement and its closing in Dec 2025 and Jan 2026 produced small or negative reactions. Today’s RSU inducement grants fit into an ongoing pattern of expansion and talent investment alongside acquisitions and customer growth.

Key Terms

restricted stock units, rsus, nasdaq listing rule 5635(c)(4)

3 terms

restricted stock units financial

"granted an aggregate of 477,208 restricted stock units (RSUs) to 25 newly hired"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

rsus financial

"aggregate of 477,208 restricted stock units (RSUs) to 25 newly hired employees"

RSUs, or restricted stock units, are a form of company shares given to employees as part of their compensation. They are typically awarded with certain restrictions, such as a waiting period before they can be fully owned or sold, similar to earning a gift that becomes fully yours over time. For investors, RSUs can impact a company's stock offerings and reflect how much the company relies on stock-based incentives to attract and retain talent.

nasdaq listing rule 5635(c)(4) regulatory

"The grants were made in accordance with Nasdaq Listing Rule 5635(c)(4)."

NASDAQ Listing Rule 5635(c)(4) is a rule that requires a company to get approval from its shareholders before selling a large amount of its shares, usually over 20%. This helps protect investors by making sure the company doesn't flood the market with new shares without their say, which could lower the stock's value.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

CAMPBELL, Calif., Jan. 16, 2026 (GLOBE NEWSWIRE) -- Arteris, Inc. (Nasdaq: AIP), a leading technology provider for accelerating semiconductor creation in the AI era, today announced that the compensation committee of the company’s board of directors has granted an aggregate of 477,208 restricted stock units (RSUs) to 25 newly hired employees as inducement awards under the company’s 2022 Employee Inducement Incentive Plan. The grants were made in accordance with Nasdaq Listing Rule 5635(c)(4).

The effective RSU grant date was January 15, 2026 and it was approved by the company’s board of directors.

About Arteris

Arteris is a leading provider of semiconductor technology that accelerates the creation of high-performance, power-efficient silicon with built-in safety, reliability, and security. Innovative Arteris products are designed to optimize data movement and help ease complexity in the modern AI era with network-on-chip (NoC) interconnect intellectual property (IP), system-on-chip (SoC) software for integration automation and hardware security assurance. All are used by the world's top technology companies to improve overall performance and engineering productivity, reduce risk, lower costs, and bring cutting-edge designs to market faster. Learn more at arteris.com.

© 2004-2026 Arteris, Inc. All rights reserved worldwide. Arteris, Arteris IP, the Arteris IP logo, and the other Arteris marks found at https://www.arteris.com/trademarks are trademarks or registered trademarks of Arteris, Inc. or its subsidiaries. All other trademarks are the property of their respective owners.

Investor Contacts:
Arteris
Nick Hawkins
IR@arteris.com

Sapphire Investor Relations, LLC
Erica Mannion and Michael Funari
+1 617 542 6180
IR@arteris.com

Media Contact:
Gina Jacobs
Arteris
+1 408 560 3044
newsroom@arteris.com

This press release was published by a CLEAR® Verified individual.

FAQ

How many RSUs did Arteris (AIP) grant as inducement awards on January 15, 2026?

Arteris granted an aggregate of 477,208 RSUs effective January 15, 2026.

How many employees received inducement RSU grants from Arteris (AIP)?

25 newly hired employees received inducement RSU awards.

Under which plan were the Arteris (AIP) inducement awards granted?

The awards were granted under the 2022 Employee Inducement Incentive Plan.

Did Arteris (AIP) comply with Nasdaq rules for the inducement RSU grants?

Yes. The grants were made in accordance with Nasdaq Listing Rule 5635(c)(4) and approved by the board.

Will the Arteris (AIP) inducement RSU grants dilute existing shareholders?

The announcement discloses the aggregate RSU amount but does not state the percentage dilution or share-count impact.